Industry veteran Peter C. Wulff joins Glucotrack to drive financial strategy and commercialization of its continuous blood glucose monitor for people with diabetesRUTHERFORD, N.J., Jan. 29, 2025 ...

RUTHERFORD, N.J., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on ...

Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), a medical technology company focused on the design, development, and commercialization ...

Nisa Investment Advisors LLC grew its holdings in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC – Free Report) by 973.3% during the 4th quarter, Holdings Channel.com reports. The institutional ...

Alphatec Holdings , Inc. (NASDAQ:ATEC), a medical device company with a market capitalization of $1.6 billion, saw its CEO Miles Patrick recently execute a sale of 43,459 shares of common stock, ...

Prior to JenaValve, Mr. Wulff served as the financial corporate officer for medical technology companies including Alphatec Spine Holdings ... strategic vision of the Company,” said Mr. Wulff.

Glucotrack, Inc., a medical technology company specializing in diabetes ... officer for medical technology companies including Alphatec Spine Holdings, Artes Medical, CryoCor and Pure Biosciences.